ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,378.78
0.40%
S&P 500
5,333.04
0.49%
Dow Jones
39,648.05
-0.06%
US Dollar vs Yen
156.7225
0.01%
Brent Oil
82.645
1.37%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. CollPlant Biotechnologies Ltd (CLGN)

  7. CollPlant Biotechnologies Ltd (CLGN) ニュース

CLGN

CollPlant Biotechnologies (CLGN)

CollPlant Biotechnologies Ltd
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CLGN
日付受信時刻ニュースソース見出しコード企業名
2024/04/0420 : 31IH Market NewsUS Index Futures Rise, Oil Dips SlightlyNASDAQ:CLGNCollPlant Biotechnologies Ltd
2024/02/1522 : 19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
2024/02/1522 : 00PR Newswire (US)CollPlant Issues Letter to ShareholdersNASDAQ:CLGNCollPlant Biotechnologies Ltd
2024/01/2605 : 27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLGNCollPlant Biotechnologies Ltd
2024/01/0221 : 09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/11/2921 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/11/0120 : 08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/10/1105 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/09/2220 : 35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/09/2120 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/09/1301 : 20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/09/0205 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/08/2420 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/07/1905 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/06/2620 : 10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/06/1420 : 34Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/05/2420 : 05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/04/1905 : 31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/04/1121 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/04/0421 : 59Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/04/0421 : 26Business WireStratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and OrgansNASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/03/2920 : 50Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/01/3104 : 54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/01/2421 : 00PR Newswire (US)CollPlant Issues Letter to ShareholdersNASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/01/1320 : 05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/01/1122 : 42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/01/0706 : 31Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/01/0421 : 06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/01/0421 : 00PR Newswire (US)CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of ObjectivesNASDAQ:CLGNCollPlant Biotechnologies Ltd
2023/01/0321 : 00PR Newswire (US)CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder FormNASDAQ:CLGNCollPlant Biotechnologies Ltd
 Showing the most relevant articles for your search:NASDAQ:CLGN

最近閲覧した銘柄

NYSE
VZ
Verizon Communications
USOTC
BNPQY
BNP Paribas (QX)
CCOM
SILVER
SILVER
NYSE
DIS
Walt Disney
CCOM
US100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
NYSE
KO
Coca Cola
NYSE
CVX
Chevron
USOTC
BASFY
BASF (QX)
NASDAQ
NVDA
NVIDIA
NASDAQ
AAPL
Apple
NASDAQ
GOOGL
Alphabet
NASDAQ
TSLA
Tesla
USI
USTECH100
US Tech 100
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有